ZA200510324B - Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof - Google Patents

Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof

Info

Publication number
ZA200510324B
ZA200510324B ZA200510324A ZA200510324A ZA200510324B ZA 200510324 B ZA200510324 B ZA 200510324B ZA 200510324 A ZA200510324 A ZA 200510324A ZA 200510324 A ZA200510324 A ZA 200510324A ZA 200510324 B ZA200510324 B ZA 200510324B
Authority
ZA
South Africa
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
novel method
Prior art date
Application number
ZA200510324A
Other languages
English (en)
Inventor
Dubuffet Thierry
Lecouve Jean-Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of ZA200510324B publication Critical patent/ZA200510324B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
ZA200510324A 2003-06-30 2004-06-28 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof ZA200510324B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291600A EP1362864B1 (de) 2003-06-30 2003-06-30 Verfahren für die Synthese von Perindopril und seiner pharmazeutisch geeigneten Salze

Publications (1)

Publication Number Publication Date
ZA200510324B true ZA200510324B (en) 2007-03-28

Family

ID=29266055

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200510324A ZA200510324B (en) 2003-06-30 2004-06-28 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof

Country Status (20)

Country Link
US (1) US7220776B2 (de)
EP (1) EP1362864B1 (de)
JP (1) JP4347342B2 (de)
CN (1) CN100383159C (de)
AR (1) AR044943A1 (de)
AT (1) ATE360638T1 (de)
AU (1) AU2004255899B2 (de)
CY (1) CY1106471T1 (de)
DE (1) DE60313391T2 (de)
DK (1) DK1362864T3 (de)
EA (1) EA009458B1 (de)
ES (1) ES2286393T3 (de)
HK (1) HK1089187A1 (de)
MY (1) MY136938A (de)
NZ (1) NZ544004A (de)
PL (1) PL211491B1 (de)
PT (1) PT1362864E (de)
SI (1) SI1362864T1 (de)
WO (1) WO2005005461A2 (de)
ZA (1) ZA200510324B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL380887A1 (pl) 2003-12-29 2007-04-02 Sepracor Inc. Pirolowe i pirazolowe inhibitory DAAO
PT1679072E (pt) 2005-01-06 2008-12-22 Ipca Lab Ltd Processo para a síntese de derivados de ácido (2s,3as,7as)-1-(s)-alanil-octa-hidro-1h-indole-2-carboxílico e utilização na síntese de perindopril
EP1904066B1 (de) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. KOMBINATIONEN VON ESZOPICLON UND TRANS-4-(3,4-DICHLORPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS-4-(3,4-DICHLORPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALINAMIN ZUR BEHANDLUNG DER MENOPAUSE, Perimenopause UND VON KOGNITIVEN STÖRUNGEN
CN104276955A (zh) 2006-01-06 2015-01-14 赛诺维信制药公司 基于四氢萘酮的单胺再摄取抑制剂
US20070203111A1 (en) 2006-01-06 2007-08-30 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
ES2555315T3 (es) 2006-03-31 2015-12-30 Sunovion Pharmaceuticals Inc. Preparación de amidas y aminas quirales
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
JP2008019214A (ja) * 2006-07-13 2008-01-31 Shiono Chemical Co Ltd ペリンドプリルまたはその誘導体の製造方法
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
SI1321471T1 (de) * 2003-03-12 2005-08-31 Servier Lab
ATE315043T1 (de) * 2003-06-30 2006-02-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen

Also Published As

Publication number Publication date
SI1362864T1 (sl) 2007-08-31
CY1106471T1 (el) 2012-01-25
WO2005005461A3 (fr) 2005-03-31
DK1362864T3 (da) 2007-09-17
AU2004255899A1 (en) 2005-01-20
PT1362864E (pt) 2007-07-23
EP1362864B1 (de) 2007-04-25
DE60313391D1 (de) 2007-06-06
CN100383159C (zh) 2008-04-23
EP1362864A1 (de) 2003-11-19
CN1805972A (zh) 2006-07-19
JP4347342B2 (ja) 2009-10-21
ES2286393T3 (es) 2007-12-01
AR044943A1 (es) 2005-10-12
DE60313391T2 (de) 2008-01-17
US7220776B2 (en) 2007-05-22
US20060148884A1 (en) 2006-07-06
HK1089187A1 (en) 2006-11-24
MY136938A (en) 2008-11-28
ATE360638T1 (de) 2007-05-15
EA200501900A1 (ru) 2006-06-30
NZ544004A (en) 2009-03-31
AU2004255899B2 (en) 2008-03-13
EA009458B1 (ru) 2007-12-28
PL379630A1 (pl) 2006-10-30
WO2005005461A2 (fr) 2005-01-20
JP2008500263A (ja) 2008-01-10
PL211491B1 (pl) 2012-05-31

Similar Documents

Publication Publication Date Title
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
AP2002002630A0 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
AU2001248470A1 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1089188A1 (en) Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1095839A1 (en) Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
PL1753720T3 (pl) Proces wytwarzania peryndoprylu i jego soli
SI1371659T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
HK1086281A1 (en) Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096406A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
SI1422236T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1268424T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli